Megan Skiendel: David, hey — rough week or are you energized, because I need you sharp for this one.
David Sterling: I'm fine. I've been staring at a Samsung Health app update timestamp and it keeps bothering me.
Megan Skiendel: June 8. Six weeks before the hardware.
David Sterling: June 8 — exactly. Vitals, Energy Score, Heart Health Score, all live on existing devices before anyone's seen the Galaxy Watch 9. So when Samsung walks out at Galaxy Unpacked on July 22 in London and Hon Pak says this watch is a gateway for AI — well, the gateway was already open.
Megan Skiendel: And Pak's language — listen, he didn't say health device, he didn't say smartwatch. Gateway. That's an infrastructure word.
David Sterling: Here's the point — the hardware leaks tell you the same story from the other side. 40mm and 44mm aluminum cases, Qualcomm Snapdragon chipset, Super AMOLED. Nearly identical to the prior generation. If the Galaxy Watch 9 were the product, you'd expect a chip story. There isn't one.
Megan Skiendel: So the hardware is — what, the container?
David Sterling: The delivery mechanism for consent. Samsung Electronics branded this an AI-powered Health Companion in the July 14 teaser. That framing isn't about the watch. It's about what the watch collects.
Megan Skiendel: And who inside Samsung actually won that argument — whether this gets positioned as a health data play versus a consumer electronics upgrade — that's the question I want to dig into, because Pak being the public face of this tells you something about where the organizational power landed.
David Sterling: The organizational power question is real — but pump the brakes. Before we get to who won the internal fight, what does Samsung actually have users agreeing to?
Megan Skiendel: This is the part that nobody's reading carefully. Think of it like — your fitness tracker is also quietly taking notes for its employer every time your heart rate spikes. Not storing them for you. Taking them. And the only way to stop it is to go find a settings menu and file a deletion request after the fact.
David Sterling: Wait — deletion after the fact. Not opt out before.
Megan Skiendel: After. And here's what that admission actually is — Samsung publicized those deletion controls. They said, yes, you can delete health data used for AI model training. Which means they confirmed, in public, that the data trains models at all. That's not a privacy feature. That's a disclosure they couldn't avoid making.
David Sterling: So the default is participation. You're in unless you go looking.
Megan Skiendel: And the architecture makes leaving expensive — honestly, this is the part I think gets underweighted. Samsung Health isn't just on the watch. It's stitched across the watch, the phone, the tablet. Your longitudinal health record — months, years of biometric data — lives inside that Galaxy ecosystem. Walk away from Samsung and you leave your health history behind. That's switching costs that have nothing to do with how good the hardware is.
David Sterling: Right — but the mechanism isn't conspiracy. It's architecture. That's actually the subtler problem.
Megan Skiendel: Exactly that. Nobody made a villainous choice. Someone just — designed the opt-out to require effort, and designed the data to accumulate across every Galaxy device you own. The Galaxy Watch 9 isn't the trap. Samsung Health is the trap. The watch is just the door.
David Sterling: The door opens into — well, here's where I think the hot take actually lands. These scores. Energy Score, Heart Health Score, the Vitals panel. Samsung is interpreting HRV, respiratory rate, skin temperature, blood oxygen in real time. And none of it carries FDA clearance. Not one.
Megan Skiendel: None of it.
David Sterling: Apple got FDA clearance for ECG on the Watch in 2018. That was passive sensor data with a well-understood clinical use case. Samsung's AI is doing active interpretation — turning raw biometrics into actionable guidance — and they skipped that entire process.
Megan Skiendel: Victoria Song wrote exactly this — July 6, The Verge. Her argument was that good design intentions do not resolve accountability when the guidance is wrong. And I think that sentence is the whole liability case in one line.
David Sterling: Right — but let me make it concrete. Picture someone, say a 52-year-old Galaxy Watch 8 loyalist. She wakes up, her Heart Health Score dropped overnight, there's an AI-generated alert. She calls her doctor. The score has zero medical-grade validation behind it. That call is either a false alarm that erodes trust — or it's a missed signal the AI confidently normalized. Both outcomes are Samsung's liability, and Samsung has no FDA backstop.
Megan Skiendel: Honestly, the accountability gap is worse than it looks because Samsung positioned this as a health companion, not a wellness app. That word choice does real legal work — or fails to.
David Sterling: The load-bearing assumption in their whole data moat strategy is that users trust the output enough to stay. Trust without validation is — I mean, that's not a moat. That's a liability runway.
Megan Skiendel: And that's before we get to why Samsung needed this story in the first place — the Meta number changes the entire strategic logic here, and that part makes this considerably more urgent.
David Sterling: Yeah. We're not done with that.
Megan Skiendel: And that Meta number is exactly where this stops being a health story. Zuckerberg said it on the Q1 2026 earnings call — daily usage of Meta smart glasses tripled year-over-year. Tripled. And he called it 'one of the fastest growing categories of consumer electronics ever.' That's not a product line. That's a platform announcement.
David Sterling: Wait — tripled off what base, though?
Megan Skiendel: EssilorLuxottica reported 7 million units of Ray-Ban Meta and Oakley Meta glasses sold in 2025. Wearables were the dominant driver of their wholesale growth. That's not a small base anymore.
David Sterling: Seven million. Okay, that — yeah, that's a real number.
Megan Skiendel: And now Meta's dropping a $299 version — no Ray-Ban branding, no Oakley branding — which is at least eighty dollars below the prior entry price. They're cutting the floor out. And there's a leaked internal memo from Alex Himel, VP of Wearables, showing Meta's already testing an AI pendant internally, building enterprise wearables under a 'Wearables for Work' line, running it all on an unreleased AI agent called Hatch. Samsung isn't racing one product. It's racing an entire platform expansion.
David Sterling: So Samsung cannot win on the face. One UI Watch 9, Wear OS 7, Samsung Health — that software stack becomes the only moat that's actually defensible. Because the wrist, and your existing phone relationship, is categorically different from a social media company owning your visual field.
Megan Skiendel: That's the calibrated take, I think. Samsung's data play isn't a wellness strategy — it's a defensive move against a form-factor war it already can't win on hardware. The biometric lock-in through Samsung Health is rational. It's just rational with serious unresolved costs on consent and liability.
David Sterling: Frankly — defensible, not admirable. Those are different things.
Megan Skiendel: Defensible, not admirable. That's the line.
David Sterling: Fine. It's not a conspiracy. It's capitalism with a heart rate monitor. And the thing is — I think I have to half-concede the whole frame. The consent architecture Samsung built into Samsung Health isn't malicious. It's just optimal. Opt-out AI training bundled with cloud backup, data accumulating across every Galaxy device you own. If that model works — if users don't churn, if Samsung Health premium tiers attach — every other device maker copies it before any regulator looks up from their desk.
Megan Skiendel: And the clock on that window is July 22. Galaxy Unpacked, London, Galaxy Watch 9 and the Galaxy Watch Ultra 2 on stage. Once those ship with this consent architecture baked in, it's a template. That's the uncomfortable landing here — not whether Samsung is wrong, but whether the industry just got handed a playbook before GDPR or the FDA or anyone else has modeled what continuous biometric opt-out actually means at scale.
David Sterling: We opened on a timestamp — June 8, app update, six weeks early. I keep thinking about that 52-year-old with her Watch 8 who got that notification. She's still the test case. She didn't consent to a platform shift. She tapped update.
Megan Skiendel: She tapped update. That's the whole story.
David Sterling: Worth the conversation. Thanks for the color — genuinely.
